RI-MUHC ANNUAL REPORT 2021
TOGETHER WE HAVE THE MEANS TO LEVERAGE DISCOVERIES THAT IMPROVE THE HEALTH OF PATIENTS ACROSS THEIR LIFESPAN.
The MUHC Foundation provided $16.4 million to the Research Institute of the McGill University Health Centre (RI-MUHC) in 2020-2021 to support innovation and cutting-edge research.
Over 50 projects to address the challenges of COVID‑19 were launched thanks to over $7 million in donations. McGill Interdisciplinary Initiative in Infection and Immunity (MI4) researchers studied everything from treatment to transmission to finding a vaccine. Highlights include:
- Producing reagents for COVID-19 tests to address the shortage early in the pandemic
- Testing existing drugs against COVID-19
- Determining whether plasma from recovered individuals could help patients hospitalized with COVID-19
In late 2020 the MUHC Foundation funded three projects working to reduce vaccine hesitancy in key populations, an important concern as vaccines began to roll out.
The DOvEEgene phase III clinical trial began with the support of $1.9 million in donations. This is the last step in making this early detection test for ovarian and endometrial cancers a standard of women’s care.
Over the past year, the MGHF, in close collaboration with its donor community, has invested $7.2 million in research support at the RI‑MUHC. These funds have allowed the rapid implementation of projects related to COVID-19, such as the Code Life Ventilator Challenge and COVID-19 Biobank. They have also helped our medical teams in their quest for innovation and excellence.
For example, we have been able to support research into thoracic cancers using the “organ on a chip” technology and the living biobank developed at the MGH. The vital support we received from our donors has also ensured the continuity of projects such as the Mental Health Data Centre and the use of a state-of-the-art imaging system to further our understanding of concussions. Research is the key to improving life-saving care and none of this would be possible without the generosity of our community. To all of you: thank you!
Working closely with the MGH Foundation, the MGH Auxiliary volunteers raise funds for the care and comfort of patients and for medical research and medical equipment at the MGH site of the MUHC.
Support for the RI-MUHC in 2020-2021: $4,060,662
With the onset of the COVID-19 pandemic came numerous studies on the virus, how to treat it, potential cures and its effects on the population, both physically and emotionally. The Montreal Children’s Hospital Foundation funded two pediatric research projects related to the coronavirus.
“The effects of quarantine on families,” led by Dr. Lily Hechtman, was supported by the Foundation of Stars, while the “Multi-centre, randomized, open-label, controlled clinical trial of the safety and efficacy of hydroxychloroquine for the treatment of COVID-19 in hospitalized children in Canada,” led by Drs. Jesse Papenburg and Patricia Fontela, was made possible thanks to donors to the Healthy Kids Fund.
Funding was also secured for novel research in exosomes, biological therapies, wireless vital signs monitoring, and diagnosing complications in pregnancy.
Dr. Ramy Saleh, a medical oncologist who is currently leading an international COVID-19 clinical trial at the McGill University Health Centre, launched at the RI‑MUHC, saw a need to match patients with clinical trials—and Covidtrials.ca was born.
People with cancer are at higher risk for more serious outcomes of COVID-19. Some cancer treatments can weaken the immune system, making it even harder to fight infections. Finding effective treatments and vaccines is of paramount importance. The Cedars Cancer Foundation helps fight cancer from every angle, for every cancer type and every need, regardless of the patient's age, throughout and beyond treatment. This website is a natural extension of our mission.